Fundraising FoxAccu-Break Pharmaceuticals
Hollywood, US · Delaware corporation
Find your way into Accu-Break Pharmaceuticals
Sign up to see every warm intro you have to Accu-Break Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Accu-Break Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Accu-Break Pharmaceuticals develops patent-pending tablet technologies that let pharmaceutical tablets be swallowed whole or broken into precise half, third, or quarter doses using a pharmacologically inactive break region. Its technologies target drugmakers seeking dose flexibility, product life-cycle management, and extended patent protection.
Founders & leadership
RI
Robert I. GoldfarbPresident, General Counsel & DirectorRobert Goldfarb is President, General Counsel and Secretary of Accu-Break Pharmaceuticals. He previously served as Counsel and General Counsel at Andrx Corporation from 2000 to 2006, where he managed the legal department and represented the company through its $1.9 billion acquisition by Watson Pharmaceuticals.
Board
EF
Elliot F. HahnExecutive Chairman and Director
NN
Nigel N. NortonBoard director
MH
Mel HarrisBoard director
RE
Robert E. BaldiniBoard director
DL
David LuckingBoard director
LA
Lloyd A. MoriberBoard director
JM
John M. SiebertBoard director
Reported raises · per SEC filings
Form D private placements$500K disclosed across 1 round · 2015
▶$500KraisedJun 2015 · 7 investors · PharmaceuticalsRule 506(b)
▶$500KraisedJun 2015 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Elliot F. HahnExecutive Officer, Director
- Robert I. GoldfarbExecutive Officer
- Nigel N. NortonDirector
- Mel HarrisDirector
- Robert E. BaldiniDirector
- David LuckingDirector
- Lloyd A. MoriberDirector
- John M. SiebertDirector
- Offering amount
- $1M
- Amount sold
- $500K
- First sale
- May 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
WalgreensWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.
AARPAARP Services is the commercial arm of AARP that connects companies with the 50+ population through brand licensing, marketing, audience data, and innovation services. It helps organizations develop and market products and services tailored to aging consumers while leveraging AARP's trusted brand and member insights.
1MgThis is a product listing page on an online pharmacy for Tugain Twins 5 Solution, a topical minoxidil-based medicine sold to treat hair loss and promote hair regrowth. The page provides usage instructions, benefits, side effects, and purchase/return details rather than describing a company.
Companies working in the same space as Accu-Break Pharmaceuticals.
Frequently asked questions
- What does Accu-Break Pharmaceuticals do?
- Accu-Break Pharmaceuticals develops patent-pending tablet technologies that let pharmaceutical tablets be swallowed whole or broken into precise half, third, or quarter doses using a pharmacologically inactive break region. Its technologies target drugmakers seeking dose flexibility, product life-cycle management, and extended patent protection.
- How much funding has Accu-Break Pharmaceuticals raised?
- Accu-Break Pharmaceuticals has disclosed $500K raised across 1 round.
- Where is Accu-Break Pharmaceuticals headquartered?
- Accu-Break Pharmaceuticals is headquartered in Hollywood, US.